Добірка наукової літератури з теми "Assited Reproductive Technology"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Assited Reproductive Technology".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Assited Reproductive Technology"

1

Markova, Е. А., Т. A. Kuznetsova, V. V. Vostricov, and S. V. Salfetkina. "The expediency of mandatory combined endoscopy in increasing of assited reproductive technology efficiency." Journal of obstetrics and women's diseases 54, no. 5S (November 15, 2005): 27. http://dx.doi.org/10.17816/jowd87199.

Повний текст джерела
Анотація:
Introduction. Evaluation of 168 patients participating in IVF programs was performed depending on the results of combined endoscopic examination and subsequent treatment. The pathology of endometrium was detected in more than half of the cases, while hydrosalpinx was revealed in 20% of the patients, and every tenth patient suffered from endometriosis. The expediency of the approach under the study for preparing the patients for IVF programs has been confirmed. The present study was aimed an evaluation of expediency and efficacy of combined endoscopic examination in preparing for subsequent participation of female patients in IVF programs.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Deep, JP. "Assisted Reproductive Technology." Journal of Chitwan Medical College 4, no. 1 (July 30, 2014): 1–10. http://dx.doi.org/10.3126/jcmc.v4i1.10840.

Повний текст джерела
Анотація:
All the treatment or procedure that includes the handling of both human sperm and oocytes or embryos in vitro for the purpose of establishing a pregnancy in order to bypass some pathological obstacles in human reproduction is known as Assisted Reproductive Technology (ART). Now we must be approaching 1.5 million Assisted Reproductive Technology birth since the birth of the world’s first in vitro fertilization baby, Louise Brown, in the United Kingdom. The infertility is caused by various reason and factors from either or both partners. Infertility affects worldwide by 8-15 percent of couples in general and defined as a disease of the reproductive system by the failure to achieve a clinical pregnancy after one year or more of regular unprotected sexual intercourse. DOI: http://dx.doi.org/10.3126/jcmc.v4i1.10840 Journal of Chitwan Medical College 2014; 4(1): 1-10
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Bhardwaj, Peehu. "Critical Analysis of the Assisted Reproductive Technology (Regulation) Act, 2021." International Journal of Science and Research (IJSR) 13, no. 2 (February 5, 2024): 661–63. http://dx.doi.org/10.21275/sr24204205741.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Kaur, Gurwinder, Neelam Chaudhary, and Harpreet Kaur. "Structured Teaching Program on Assisted Reproductive Technology among Nursing Students." International Journal of Science and Research (IJSR) 11, no. 2 (February 5, 2022): 1121–23. http://dx.doi.org/10.21275/sr22223154109.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Peters, Kathleen, Debra Jackson, and Trudy Rudge. "Failures of reproduction: problematising ?success? in assisted reproductive technology." Nursing Inquiry 14, no. 2 (June 2007): 125–31. http://dx.doi.org/10.1111/j.1440-1800.2007.00363.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Lakshmanan, Krishnavignesh. "A Study on the Impact of Endoscopic Myomectomy on Reproductive Outcomes of Assisted Reproductive Technology." Chettinad Health City Medical Journal 13, no. 03 (September 30, 2024): 18–22. http://dx.doi.org/10.24321/2278.2044.202439.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ceballos, Martha. "From the Grave to the Cradle: Looking for Answers to the Question of Consent to Reproduce Posthumously in New Zealand." Victoria University of Wellington Law Review 50, no. 3 (October 1, 2019): 433. http://dx.doi.org/10.26686/vuwlr.v50i3.5982.

Повний текст джерела
Анотація:
In New Zealand, posthumous reproduction is regulated by the Human Assisted Reproductive Technology Act 2004 (HART Act), which established two bodies, the Advisory Committee on Assisted Reproductive Technology (ACART) and the Ethics Committee on Assisted Reproductive Technology (ECART). In 2000, the predecessor of ECART, the National Ethics Committee on Assisted Human Reproduction (NECAHR), issued "Guidelines for the Storage, Use, and Disposal of Sperm from a Deceased Man" designed to provide a legal framework for this technology. However, a recent application to the High Court by the partner of a man who unexpectedly died, requesting permission to have sperm retrieved from the deceased and the subsequent judgment handed down by the High Court in 2017, have highlighted the shortcomings of the current posthumous reproduction regulations. This has led to a recent consultation process by ACART to review and revise the guidelines. Relying on Re Lee, the landmark judgment of the High Court that found in favour of granting the permission sought and which sheds light on the legal aspects of posthumous reproduction in New Zealand, the current article discusses the approach endorsed by the HART Act regarding consent for posthumous retrieval and use of gametes.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Lam, Carla. "Thinking Through Post-constructionism: Reflections on (Reproductive) Disembodiment and Misfits." Studies in Social Justice 10, no. 2 (December 19, 2016): 289–307. http://dx.doi.org/10.26522/ssj.v10i2.1352.

Повний текст джерела
Анотація:
In this article, I draw together feminist research on the distinct areas of assisted human reproduction (or new reproductive technology) and post-constructionist theory to examine some common methodological and epistemological issues fundamental for reproductive justice. I revisit the notion of technologically-assisted (reproductive) disembodiment (e.g., in vitro fertilization, surrogacy and egg donation) in light of theoretical developments in feminism, in particular post-constructionism. Specifically, I ask what light is shed on the paradox of reproduction (in particular disembodied reproduction) by feminist post-constructionism?
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Sun, Christie L., Sally L. Catt, Kiri Beilby, and Mulyoto Pangestu. "Cyclic nucleotide in oocyte In vitro maturation in Assisted Reproductive Technology." Journal of Biomedicine and Translational Research 6, no. 3 (December 23, 2020): 110–20. http://dx.doi.org/10.14710/jbtr.v6i3.9691.

Повний текст джерела
Анотація:
In vitro maturation (IVM) is a promising assisted reproductive technology (ART) for human infertility treatment. However, when cumulus oocyte complexes (COCs) are removed from their follicular environment when manipulated in vitro, it can lead to a decrease of intra-oocyte cyclic adenosine 3’, 5’-monophosphare (cAMP) causing spontaneous nuclear maturation and an asynchrony with the oocytes’ cytoplasmic maturation, resulting in poor embryo developmental outcomes. Nuclear and cytoplasmic synchrony is important during oocyte maturation within antral follicles.It is maintained partially by the actions of c-type natriuretic peptide (CNP) binding with natriuretic peptide receptor 2 (NPR2), supporting high cAMP levels thus holding the oocyte in meiotic arrest. Addition of CNP to pre-IVM media has the capacity of maintaining cAMP levels and thus improve synchrony. Moreover, in women with advanced maternal age, successful IVM of aging oocytes faces significant challenges due to the morphological and cellular changes. Inhibiting initiation of nuclear maturation by cAMP modulator, CNP during pre-IVM period and thus improve oocyte developmental competence regardless of oocyte age.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

C Suguna, T. "Effectiveness of Video Assisted Teaching Programme on Knowledge Regarding Assisted Reproductive Technology among Infertile Women." International Journal of Science and Research (IJSR) 10, no. 2 (February 27, 2021): 1235–37. https://doi.org/10.21275/sr21221113526.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Assited Reproductive Technology"

1

Morgan, Jonathan J. "State Regulation of Assisted Reproductive Technology." BYU ScholarsArchive, 2010. https://scholarsarchive.byu.edu/etd/2206.

Повний текст джерела
Анотація:
State regulation of assisted reproductive technology (ART) has been occurring since the inception of earlier technological advances such as artificial insemination to aid human reproduction. I provide a brief overview of the current regulation of ART in the U.S. and the literature on state regulation. Unlike previous studies of ART regulation which use content analysis or case studies of individual state laws I estimate ART regulation for the entire U.S. by using a series of random effects logistic regression models for the time period 1995-2006. To my knowledge this is the first quantitative analysis of ART regulation. I test the hypothesis that the demand for ART is an important predictor of ART legislation in the U.S. Other hypotheses derived from the ART literature were also tested in the analysis. Results indicate that demand for ART is the most influential factor in predicting ART legislation from 1995-2006. Additionally, educational attainment of a state's population and the percentage of married couple households with children in each state may have a direct effect on the demand for ART and an indirect effect on ART regulation.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Batty, Lynne Patricia. "Assisted Reproductive Technology: The Aotearoa/New Zealand Policy Context: A thesis submitted in fulfilment of the requirements for the degree of Master of Arts in Sociology in the University of Canterbury." Thesis, University of Canterbury. Sociology, 2002. http://hdl.handle.net/10092/912.

Повний текст джерела
Анотація:
The focus of this thesis is the current policy situation in relation to assisted reproductive technologies (ART) in Aotearoa/New Zealand. I explore how government policies (and lack of policy) have shaped access to ART. I also explore the policy initiatives of funding agencies, the National Ethics Committee on Assisted Human Reproduction (NECAHR), managers, healthcare professionals, and interest groups. My investigation into ART policy issues critically examines the various formal mechanisms and policies used to regulate and control ART in Aotearoa/New Zealand. Drawing on my analysis of policy-focused documents and material from in-depth interviews with key actors in the policy debate, I demonstrate how the ad hoc and contingent approach to ART developments, practices, funding, and access has contributed to inconsistent and inequitable access to ART services. I argue that the lack of an ART-specific policy organisation contributes to fragmented, and possibly discriminatory, policy decisions. I examine how the use of restrictive access criteria to manage the increasing demand for publicly funded ART services disadvantages certain groups wishing to use these services. By investigating the influence of rationing strategies on the allocation of resources and regulation of access, I provide some appreciation of the 'messy reality' of policy creation, interpretation, and implementation. I argue that the criteria used to limit access to public ART services obscure the use of social judgements and provider discretion. Likewise, they succeed in limiting publicly funded ART treatments to those who conform most effectively to the normative definition of family. My analysis of the ART policy discourse identifies silences and gaps in relation to specific ART practices, particularly the use of ART by Maori. I highlight the invisibility and marginalisation of Maori within the ART policy debate. After examining the broader issues concerning Maori access to health services, I explore how these may affect Maori using ART services to overcome infertility. I argue that the gathering of information about the utilisation of ART services is crucial for the accurate identification of the needs of Maori. It is also fundamental for effective monitoring of state health policy decisions and outcomes.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Hamdan, Mukhri. "Endometriosis and assisted reproduction technology." Thesis, University of Southampton, 2016. https://eprints.soton.ac.uk/416621/.

Повний текст джерела
Анотація:
Endometriosis is a disease that is historically known to present in many guises. Since 13th century it has been metaphorically regarded as an animalistic womb causing female hysteria. Albeit widely researched, significant controversies that surround the disease remain unsolved, from the clinical presentations, diagnosis, right through to its management strategies. Despite the rapid advancement of technology in modern medicine, the ideal diagnostic and investigative tool of the disease remains elusive, and hence the management of the disease remains a challenge to clinicians. Whilst it is long known that endometriosis is detrimental to fertility, it is unclear if Assisted Reproductive Technology (ART) obliterates that risk. This thesis aims to investigate the impact of different stages and types of endometriosis on ART outcomes, and how various surgical interventions influence the reproductive outcomes. The thesis will also focus on answering two important questions in endometriosis research, that of whether and how endometriosis impacts on 1) the developing oocytes and embryo, and 2) the endometrium. The thesis begins with the introduction of two robust systematic reviews and meta-analyses, which concluded that women with endometriosis had a lower pregnancy rate and fewer oocytes retrieved during ART. Worse reproductive outcomes were found in those with more severe disease. Surgical treatment, which traditionally is thought to be beneficial, was found to result similar reproductive outcome in diseased and controls, and possibly more harm. Gathering evidence retrospectively from the IVF databases supported the former conclusion that women with endometriosis undertaking ART had lower number of oocytes collected from matured follicles, and further investigation into the laboratory details showed that women with endometriosis had a higher proportion of early embryo arrest. A mouse oocyte model was then utilised to explore the influence of follicular fluid of women with endometriosis on oocyte development. The study found that follicular fluid retrieved from women with endometriosis results in the activation of DNA damage response pathway, which in turn prevented normal oocyte maturation. These effects were found reversed by the agent resveratrol. The thesis concludes with a biomarker discovery study on the endometrium of women with endometriosis compared to controls using a highly sensitive and specific state of the art proteomics analysis method (liquid chromatography mass spectrometry with isobaric tag for relative and absolute quantitation (LCMS/MS iTRAQ®) which uncovered unique proteins not yet described in the literature. Endometriosis is a disease that is detrimental to the reproductive outcomes of those undergoing ART. Its influence on reproduction is complex, but it is now clear that its impact on reproduction does not stop at the traditionally viewed anatomical distortion with resultant subfertility; but have far reaching consequences including that of defective oocyte and embryo development, with a differential impact on the endometrial proteome. The solution to this challenging disease partly lies in the early diagnosis and treatment of the condition; as such not withstanding pitfalls and fallacies surrounding biomarker discovery research, the ultimate validation of a diagnostic panel of biomarkers for the non-invasive diagnosis of endometriosis is now urgently needed.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Wilson, Poe Emma. "Vitrification of day 5/6 human morulas/blastocysts: A 10 year retrospective study in a private assisted reproductive techniques [ART] clinic." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96876.

Повний текст джерела
Анотація:
Thesis (MMed)--Stellenbosch University, 2015.
ENGLISH ABSTRACT: This study was designed to retrospectively evaluate the established embryo vitrification/warming programme currently implemented at Drs Aevitas Institute for Reproductive Medicine and to look at factors that might play a role in optimizing the pregnancy outcomes thereof. Vitrification is the achievement of a “state of suspended animation” wherein molecular translational motions are arrested without structural reorganization of the liquid. In embryo vitrification it involves placement of the embryo in a very small volume of vitrification medium that must be cooled at extremely high cooling rates. The vitrification medium contains cryoprotectants to prevent any cryoinjury from occurring to the embryo. This process was initially proposed to effectively manage supernumerary embryos, but it has also provided a viable method of reducing costs for additional embryo transfers as well as the reduction of the incidence of multiple births. Patients who are at risk of ovarian hyper stimulation syndrome (OHSS) can also have all of their embryos vitrified in advance to reduce the likelihood of adverse clinical symptoms if a pregnancy is established. Throughout the period in which vitrification has been in practice, there have been advances in technology as well as continual research being conducted to establish whether newly suggested techniques do, in fact, optimize the outcomes of vitrification. Focus has subsequently been applied to the carrier device used for vitrification, the day on which the embryos are vitrified and stored, as well as the number of embryos transferred in each respective cycle, all to ensure the most favourable outcome. This retrospective study confirmed the use of the Cryotop® as the most viable carrier device for successful survival and pregnancy outcomes. Transfer of day 5 vitrified embryos resulted in significantly higher pregnancy rates compared to day 6 vitrified embryos. Results also indicated that the number of embryos transferred does indeed have a significant effect on the pregnancy outcome and consequently we can possibly argue against the implementation of single embryo transfer in the vitrification programme. Investigation into the effect of female age, specifically oocyte age, on each of these categories indicated that reduced age can be associated with optimal outcomes; however this could not be proven statistically in this cohort of patients. To further look at optimization of the vitrification/warming programme, a Literature Survey was conducted to ascertain the results after Assisted Hatching in frozen/warmed human embryos. Assisted Hatching has been proposed as a solution to Zona Pellucida hardening, which has been found to occur during vitrification. The need for further studies and a meta-analysis of the literature is confidently proposed, as well as a Prospective Study to evaluate the effect of Laser Assisted Hatching in the human blastocyst vitrification/warming programme at Drs Aevitas Institute for Reproductive Medicine.
AFRIKAANSE OPSOMMING: Hierdie studie is ontwerp om die gevestigde embrio vitrifikasie/ontdooi program by Drs Aevitas Instituut vir Reproduktiewe Medisyne, retrospektief te evalueer en die faktore te optimaliseer wat swangerskap uitkomste kan beïnvloed. Vitrifikasie is die proses waardeur die molekulere aktiwiteit binne die embrio in ‘n staat van arres gehou word sonder om die strukture binne die sitplasma te versteur. Dit behels die plasing van ʼn embrio in 'n klein hoeveelheid vitrifikasie medium wat teen 'n hoë tempo afgekoel word. Die vitrifikasie medium bevat kriobeskermmiddels wat die embrio tydens die vitrifikasie proses teen moontlike skade beskerm. Hierdie proses is aanvanklik voorgestel om oortollige embrio’s doeltreffend te bestuur. Dit bied ʼn koste effektiewe metode vir embrio terugplasing, en verlaag die insidensie van veelvoudige swangerskap. Vitrifikasie bied pasiënte met ʼn hoë risiko vir ovariale hiperstimulasiesindroom (OHSS) ‘n alternatief om nadelige kliniese simptome te vermy indien ʼn swangerskap bereik word. Tegnologiese vordering en voortdurende navorsing ondersoek voortdurend nuwe tegnieke vitrifikasie uitkomste te optimaliseer. Fokus word geplaas op die draertoestel wat gebruik word vir vitrifikasie, die dag waarop die embrio's gevitrifiseer en gestoor word, sowel as die aantal embrio’s wat met elke vitrifikasie siklus teruggeplaas word. Hierdie retrospektiewe studie het bevestig dat die gebruik van die Cryotop® die mees suksesvolle toestel vir oorlewing en swangerskap uitkomste is. Die terugplasing van dag 5 gevitrifiseerde embrios het beduidende hoër swangerskapsyfers as dag 6 embrios tot gevolg gehad. Die resultate het ook aangedui dat die aantal embrio's wat teruggeplaas word 'n beduidende uitwerking op die swangerskapsyfer het. Daar kan dus moontlik teen die implementering van 'n enkel embrio-terugplasing neiging in die vitrifikasie program geargumenteer word. Resultate het ook getoon dat optimale uitkomste verwant is aan ʼn laer oösiet ouderdom, alhoewel dit nie in die groep pasiente statisties bewys kon word nie. 'n Literatuurstudie oor AH (Assisted Hatching) op gevitrifiseerde/ontdooide menslike embrio’s is uitgevoer om die vitrifikasie/ontdooi program verder te optimaliseer. AH bied ‘n oplossing vir Zona pellucida verharding, wat tydens vitrifikasie plaasvind. Verdere studies, 'n meta-analise van die literatuur, sowel as 'n prospektiewe studie om die effek van laser AH in gevitrifiseerde/ontdooide menslike blastosiste by Drs Aevitas Instituut vir reproduktiewe medisyne te evalueer, word voorgestel.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Mayeur, Anne. "La prévention des maladies mitochondriales par mutation de l'ADNmt : de la clinique au transfert de pronoyaux." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASL084.

Повний текст джерела
Анотація:
Les mitochondries ont la particularité de posséder leur propre génome, l'ADN mitochondrial (ADNmt), transmis exclusivement par la mère via le cytoplasme de l'ovocyte. Les mutations pathogènes au sein de l'ADNmt sont à l'origine des maladies mitochondriales. Le transfert de pronoyaux (TPN), non autorisé en France, est une technique proposée depuis 2016 par le Royaume Uni afin de substituer le génome mitochondrial muté d'un zygote par un autre non muté. Cette méthode reste largement débattue sur le plan international en termes d'efficacité et de sécurité. L'objectif de nos travaux était d'évaluer la faisabilité clinique et technique du TPN. Nos recherches ont confirmé que les femmes porteuses d'un variant pathogène de l'ADNmt présentaient des critères de réponse ovarienne à la stimulation comparable à un groupe contrôle. Grâce à une étude sociologique nous avons également montré que cette technique recevait une adhésion par la grande majorité des femmes interrogées principalement car elle permet de maintenir un lien génétique entre une femme et son enfant. Puis nous avons mis au point la technique de TPN en utilisant des zygotes triploïdes (3PN) donnés à la recherche et après autorisation de l'Agence de Biomédecine. Enfin, nous avons évalué la pertinence de l'utilisation des 3PN et démontré leurs limites en termes de développement et de statut chromosomique, même lorsque la diploïdie était rétablie. Ces travaux ouvrent des perspectives sur la faisabilité et l'acceptation du TPN. De futures recherches sont nécessaires pour explorer la sécurité de cette technique
Mitochondria have the unique characteristic of possessing their own genome, mitochondrial DNA (mtDNA), which is exclusively transmitted by the mother through the cytoplasm of the oocyte. Pathogenic mutations in mtDNA are responsible for mitochondrial diseases. Pronuclear transfer (PNT), not authorized in France, is a technique proposed by the United Kingdom since 2016 to replace the mutated mitochondrial genome of a zygote with a non-mutated one. This method remains widely debated internationally regarding its efficacy and safety. The aim of our work was to evaluate the clinical and and technical feasibility of PNT. Our research confirmed that women carrying a pathogenic variant of mtDNA exhibited ovarian response criteria to stimulation comparable to a control group. Through a sociological study, we also showed that this technique received support from the majority of women surveyed, primarily because it maintains a genetic link between a woman and her child. Subsequently, we developed the PNT technique using triploid zygotes (3PN) donated for research, following authorization from the Biomedicine Agency. Finally, we assessed the relevance of using 3PN and demonstrated their limitations in terms of development and chromosomal status, even when diploidy was restored. This work opens up perspectives on the feasibility and acceptance of PNT. Future research is necessary to explore the safety of this technique
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Pangestu, Mulyoto 1963. "Drying biological material for use in assisted reproductive technology." Monash University, Institute of Reproduction and Development, 2002. http://arrow.monash.edu.au/hdl/1959.1/7879.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Chang, Jeani. "Relationship Between Assisted Reproductive Technology and Risk of Stillbirth." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4508.

Повний текст джерела
Анотація:
Assisted reproductive technology (ART) is an infertility treatment used to assist women to become pregnant. Although the procedure is safe, there are gaps in understanding the association between treatment and adverse pregnancy outcomes (e.g., stillbirth) in the United States. The purpose of this study was to investigate the relationship between stillbirth delivery and ART. The 2 research questions addressed the association between methods of conception (ART versus non-ART) and the delivery of a stillbirth, and the association between multiple gestation pregnancy and risk of stillbirths. Retrospective cohort data from the States Monitoring ART collaborative were analyzed using Pearson's chi squared tests and log binominal regression models. Findings indicated that from 2006 to 2011, the average stillbirth rates were lower among ART-conceived pregnancies than non-ART conceived pregnancies. After controlling for confounding factors, ART-conceived pregnancies did not show increased risks of stillbirths compared to non-ART conceived pregnancies regardless of plurality. This lower risk of stillbirth was particularly significant during early pregnancies, before 28 weeks of gestation. Findings may be used to improve understanding of the use of ART treatment and its associated pregnancy outcomes. Findings may also be used to prevent stillbirths and to improve prenatal care, early stillbirth detection, and effective clinical management of fetal and maternal conditions during pregnancy.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sengupta, Anindita. "The Desired Baby: Assisted Reproductive Technology, Secrecy, and a Cultural Account of Family Building in India." The Ohio State University, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=osu1483451149153858.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

McComiskey, Mark Henry. "Unrecognised healthcare consequences of children born following assisted reproductive technology." Thesis, Queen's University Belfast, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675460.

Повний текст джерела
Анотація:
The consensus is that children born following ART are delivered earlier and at a lower birthweight that those naturally conceived and have a higher likelihood of requiring admission to a neonatal intensive care unit (NICU). The longer term prospects for artificially conceived children seem comparable to the naturally conceived population for the majority of medical conditions. This study examined NICU admission registry data of children born 111/2001 to 31/12/2007. Odds ratios (OR) for NICU admission were produced. All paediatric hospital admissions in Northern Ireland 1/7/1996 through 3016/2009 were also studied. Standardised admission ratios (SAR's) for children up to 13 years old born following ART were calculated. Unadjusted OR for NICU admission was 0.92 (95% CI 0.71, 1.18) for singleton~ and 0.83 (95% CI 0.69, 0.99) for twins. Adjustment for hospital, gestation and year showed OR for NICU admission to be 0.68 (95% CI 0.49, 0.93) for singletons and 0.76 (95% CI 0.60, 0.97) for twins. SAR for all- and first hospital admissions in ART children were 80 (95% CI 76, 84) and 74 (95% CI 68, 80) respectively. Children born fOllowing IVF had increased all-hospital SAR compared to those born following ICSI (SAR 85, 95% CI 80, 90 vs. SAR 71,95% C164, 77; p=0.001). Those born following fresh embryo had increased all-hospital SAR compared to those born fallowing frozen embryo transfer. All-admission analysis showed Significant increases in SAR with diagnoses of cerebral palsy and inguinal hernia. Non-significant trend for increased SAR for all-hospital admission and first-hospital admission was found for some diagnoses. This study adds some reassurance to the neonatal and long-term child health of those born following ART. IVF children and those born following fresh embryo transfer may not be as healthy throughout childhood as their ICSI and frozen embryo transfer peers. Published concerns regarding neurological conditions and congenital abnormalities in children conceived using ART are supported by this study.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Hui, Pui-wah. "Nuchal translucency in pregnancies conceived after assisted reproduction technology." Click to view the E-thesis via HKUTO, 2003. http://sunzi.lib.hku.hk/hkuto/record/B31971040.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Assited Reproductive Technology"

1

P, Marrs Richard, ed. Assisted reproductive technologies. Boston: Blackwell Scientific Publications, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Hafez, E. S. E. 1922-, ed. Assisted human reproductive technology. New York: Hemisphere Pub. Corp., 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gardner, David K., Botros R. M. B. Rizk, and Tommaso Falcone, eds. Human Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2009. http://dx.doi.org/10.1017/cbo9780511734755.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Hafez, E. S. E. 1922-, ed. Assisted human reproductive technology. New York: Hemisphere, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

editor, Sarojini N. B., Marwah Vrinda editor, and Sama--Resource Centre for Women and Health (New Delhi, India), eds. Reconfiguring reproduction: Feminist health perspectives on assisted reproductive technologies. New Delhi: Published by Zubaan Publishers Pvt. Ltd., in collaboration with Sama-Resource Group for Women and Health, 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

K, Gardner David, ed. Textbook of assisted reproductive techniques: Laboratory and clinical perspectives. 2nd ed. London: Taylor & Francis, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

K, Gardner David, ed. Textbook of assisted reproductive techyniques: Laboratory and clinical perspectives. 2nd ed. London: Martin Dunitz ; Boca Raton, FL, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Jauniaux, Eric, and Botros Rizk, eds. Pregnancy After Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2012. http://dx.doi.org/10.1017/cbo9780511902604.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Broyde, Michael J. Assisted reproduction and Jewish law. Cincinnati, Ohio: Dept. of Judaic Studies, University of Cincinnati, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Stevenson, Eleanor L., and Patricia E. Hershberger, eds. Fertility and Assisted Reproductive Technology (ART). New York, NY: Springer Publishing Company, 2016. http://dx.doi.org/10.1891/9780826172549.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Assited Reproductive Technology"

1

Abrams, David B., J. Rick Turner, Linda C. Baumann, Alyssa Karel, Susan E. Collins, Katie Witkiewitz, Terry Fulmer, et al. "Assisted Reproductive Technology." In Encyclopedia of Behavioral Medicine, 139. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_100120.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Vukadinovich, David M., and Susan L. Krinsky. "Assisted Reproductive Technology." In International Library of Ethics, Law, and the New Medicine, 89–111. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-015-9674-9_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Fauser, Bart C. J. M., and Didi D. M. Braat. "Assisted reproductive technology." In Textbook of Obstetrics and Gynaecology, 263–82. Houten: Bohn Stafleu van Loghum, 2019. http://dx.doi.org/10.1007/978-90-368-2131-5_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Datta, Sanjay, Bhavani Shankar Kodali, and Scott Segal. "Assisted Reproductive Technology." In Obstetric Anesthesia Handbook, 387–98. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-88602-2_18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Matteo, Maria. "Assisted Reproductive Technology." In Practical Clinical Andrology, 237–50. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11701-5_18.

Повний текст джерела
Анотація:
AbstractThe human species is biologically distinguished by low fertility. In fact, with each menstrual cycle, a couple at the peak of their reproductive capacity has only about a 30% chance of conceiving. The WHO states infertility as “a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected intercourse.”Assisted reproductive technology (ART) consists of all treatments or procedures that include the in vitro handling of both human oocytes and sperm or of embryos, for the purpose of establishing a pregnancy.The techniques are usually divided into three broad categories: First level techniques: Intrauterine and Intracervical Insemination (IUI/ICI), the simpler and less invasive ones, such as intrauterine insemination (IUI) with or without Intracervical Insemination (ICI) ovarian stimulation. Second level techniques: the more complex and more invasive ones that can be performed under local anesthesia or deep sedation, which differ from the basic techniques as they involve manipulation of female and male gametes and because they require in vitro fertilization. Among these techniques the IVF (In Vitro Fertilization and Embryo Transfer), ICSI (Intracytoplasmic Sperm Injection), and the possible cryopreservation of male and female gametes and embryos. Third level techniques procedures that require general anesthesia with intubation, including: laparoscopic egg retrieval, intra-tubal transfer of male and female gametes (GIFT), zygotes (ZIFT) and /or embryos (TET) laparoscopically; microsurgical sampling of gametes from the testicle: Testicular Sperm Extraction (TESE), Microsurgical Testicular Sperm Extraction (microTESE), Testicular Sperm Aspiration (TESA); microsurgical sampling of gametes from the epididymides: Percutaneous Epididymal Sperm Aspiration (PESA) and Microsurgical Epididymal Sperm Aspiration (MESA). In all assisted reproduction techniques, the seminal fluid receives a treatment able to induce capacitation “in vitro” so that the activated spermatozoa, at the threshold of the acrosomal reaction, can interact with the mature oocytes. Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) are highly specialized procedures which involve removing three to four cells from a 5–6 day old blastocyst and testing them for chromosomal abnormalities prior to transferring the embryo into a woman’s uterus. According to data reported from the European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), the clinical pregnancy rates (PR) per aspiration and per transfer are 28.0% and 34.8%, respectively. After ICSI, the corresponding rates are 24% and 33.5%. ART can alleviate the burden of infertility on individuals and families, but it can also present challenges to public health as evidenced by the high rates of multiple delivery, preterm delivery, and low birth-weight delivery experienced with ART.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

ten Have, Henk, and Maria do Céu Patrão Neves. "Assisted Reproductive Technology." In Dictionary of Global Bioethics, 137. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_65.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kodali, Bhavani Shankar, and Scott Segal. "Assisted Reproductive Technology." In Datta's Obstetric Anesthesia Handbook, 411–25. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-41893-8_18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Pereira, Nigel, and Zev Rosenwaks. "Assisted Reproductive Technology." In Problem-Focused Reproductive Endocrinology and Infertility, 213–21. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-19443-6_30.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Fauser, Bart C. J. M., and Annemieke Hoek. "Assisted reproductive technology." In Textbook of Obstetrics and Gynaecology, 315–32. Houten: Bohn Stafleu van Loghum, 2024. http://dx.doi.org/10.1007/978-90-368-2994-6_19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Hafez, E. S. E., B. Hafez, and S. D. Hafez. "Assisted reproductive technology." In An Atlas of Reproductive Physiology in Men, 163–74. London: CRC Press, 2024. http://dx.doi.org/10.1201/9781003579526-13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Assited Reproductive Technology"

1

de Haan, J., CJM de Groot, A. Bouwman, MB Crijns, ACJ van Akkooi, F. Amant, and CAR Lok. "P99 Recurrent melanoma after pregnancy and assisted reproductive technology." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.159.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Bajkovec, Lucija, Ines Begović, Ana-Marija Đaković, Milan Milošević, Urelija Rodin, and Aida Mujkić. "475 Assisted reproductive technology techniques and risk for neurodevelopmental disorders." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.475.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Koseki, Susumu, Kazuhiro Kawamura, Futoshi Inoue, Koji Ikuta, and Masashi Ikeuchi. "Magnetically Controlled Microrobot for Embryo Transfer in Assisted Reproductive Technology." In 2019 20th International Conference on Solid-State Sensors, Actuators and Microsystems & Eurosensors XXXIII (TRANSDUCERS & EUROSENSORS XXXIII). IEEE, 2019. http://dx.doi.org/10.1109/transducers.2019.8808545.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Lepore, Mario, and Antonio Petruzziello. "A Situation-Aware DSS to Support Assisted Reproductive Technology Outcome Prediction." In 2021 IEEE Conference on Cognitive and Computational Aspects of Situation Management (CogSIMA). IEEE, 2021. http://dx.doi.org/10.1109/cogsima51574.2021.9475933.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

HongQing, Liao, and Ouyang Xinping. "The effect of sperm morphology on the outcome of Assisted Reproductive Technology." In 2014 2nd International Conference on Advances in Social Science, Humanities, and Management. Paris, France: Atlantis Press, 2014. http://dx.doi.org/10.2991/asshm-14.2014.77.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Abdulrazaq, Aisha, Alessandra Ainsworth, Jeffrey Britton, Chandra Shenoy, Samir Babayev, Gregory Cascino, and Kelsey Smith. "Seizure Control in Women with Epilepsy Undergoing Assisted Reproductive Technology (P14-1.011)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000202829.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Alekseeva, Liliya L., Ayuna Ts Budatsyrenova, and Marina R. Mangataeva. "Gestation course after the methods of assisted reproductive technology in the Buryat Republic." In Eurasian paradigm of Russia: values, ideas and experience. Buryat State University Publishing Department, 2015. http://dx.doi.org/10.18101/978-5-9793-0814-2-198-200.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Li, Bing. "Research on Assisted Reproductive Technology and Gene Modification Model Based on Data Mining." In 2023 International Conference on Internet of Things, Robotics and Distributed Computing (ICIRDC). IEEE, 2023. http://dx.doi.org/10.1109/icirdc62824.2023.00006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Paolanti, Marina, Marco Mameli, Emanuele Frontoni, Giorgia Gioacchini, Elisabetta Giorgini, Valentina Notarstefano, Carlotta Zaca, Oliana Carnevali, and Andrea Borini. "Automatic Classification of Human Granulosa Cells in Assisted Reproductive Technology using vibrational spectroscopy imaging." In 2020 25th International Conference on Pattern Recognition (ICPR). IEEE, 2021. http://dx.doi.org/10.1109/icpr48806.2021.9412544.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sasaki, Hayato, Masaya Nakata, Mizuki Yamamoto, Teppei Takeshima, Yasushi Yumura, and Tomoki Hamagami. "Investigation about Control of False Positive Rate for Automatic Sperm Detection in Assisted Reproductive Technology." In 2018 IEEE International Conference on Systems, Man, and Cybernetics (SMC). IEEE, 2018. http://dx.doi.org/10.1109/smc.2018.00339.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Assited Reproductive Technology"

1

Leroux, Marie-Louise, Pierre Pestieau, and Gregory Ponthiere. The optimal design of assisted reproductive technologies policies. CIRANO, June 2022. http://dx.doi.org/10.54932/ezmm9028.

Повний текст джерела
Анотація:
This paper studies the optimal design of assisted reproductive technologies (ART) policies in an economy where individuals differ in their reproductive capacity (or fecundity) and in their wage. We find that the optimal ART policy varies with the postulated social welfare criterion. Utilitarianism redistributes only between individuals with unequal fecundity and wages but not between parents and childless individuals. To the opposite, ex post egalitarianism (which gives absolute priority to the worst-off in realized terms) redistributes from individuals with children toward those without children, and from individuals with high fecundity toward those with low fecundity, so as to compensate for both the monetary cost of ART and for the disutility from involuntary childlessness resulting from unsuccessful ART investments. Under asymmetric information and in order to solve for the incentive problem, utilitarianism recommends also to either tax or subsidize ART investments of low-fecundity-low productivity individuals depending on the degree of complementarity between fecundity and ART in the fertility technology. On the opposite, ex post egalitarianism always recommends marginal taxation.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

song, gao, Cai-qiong Zhang, Zhong-ping Bai, rong li, and Meng-qun Cheng. Assisted Reproductive Technology And Risk of Childhood Cancer Among Infertile Parents Offspring. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2024. http://dx.doi.org/10.37766/inplasy2024.7.0119.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Wang, Fangfang, Tao Yu, Xiaolu Chen, Rong Luo, and Dezhi Mu. Assisted reproductive technology and the risk of cerebral palsy in the offspring: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0060.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Harzif, Achmad, Sarah Pratamasari, Costan Rumapea, Nafi’atul Ummah, Heidi Mutia, Putri Nurbaeti, Aisyah Puspawardani, and Budi Wiweko. The Efficacy of Luteal Phase Support in Women with Polycystic Ovary Syndrome Following Assisted Reproductive Technology: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2024. http://dx.doi.org/10.37766/inplasy2024.4.0019.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Chen, Jing, Weilin Dai, Xiaoou Li, Yunyan Xianyu, and Qiang Cai. Association of assisted reproductive technology with attention-deficit/hyperactivity disorder in offspring: A protocol for a systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2023. http://dx.doi.org/10.37766/inplasy2023.11.0007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії